Melissa C. Southey

发表

FAVR (Filtering and Annotation of Variants that are Rare): methods to facilitate the analysis of rare germline genetic variants from massively parallel sequencing datasets

Andrew Lonie, Daniel J. Park, Tu Nguyen-Dumont, 2012, BMC Bioinformatics.

Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

Julian Peto, Matthias W. Beckmann, Peter A. Fasching, 2014, PLoS genetics.

Identification of Novel Genetic Markers of Breast Cancer Survival

Peter Kraft, Nazneen Rahman, Janet A. Dunn, 2015, Journal of the National Cancer Institute.

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)

Dong Liang, Brooke L. Fridley, Jennifer A. Doherty, 2015, Journal of genetics and genome research.

Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

Peter Kraft, Michael Bremer, Simon S. Cross, 2008, PLoS genetics.

Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer

Graham G. Giles, Melissa C. Southey, James G. Dowty, 2010, Cancer Prevention Research.

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

Matthias W. Beckmann, Peter A. Fasching, Simon S. Cross, 2016, American journal of human genetics.

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

Gary D. Bader, Christine L. Clarke, Gary D Bader, 2020, Nature Communications.

A Genome-wide Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age

Jianxin Shi, Daniel F. Schmidt, Nazneen Rahman, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

Mads Thomassen, Julian Peto, Peter A. Fasching, 2013, PLoS genetics.

Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics

Douglas F. Easton, Melissa C. Southey, John L. Hopper, 2003, Human Genetics.

Common variants in ZNF365 are associated with both mammographic density and breast cancer risk

Peter Kraft, Norman F. Boyd, Kamila Czene, 2011, Nature Genetics.

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival

Bernd Holleczek, Peter A. Fasching, Simon S. Cross, 2015, Oncotarget.

Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170

Wei Zheng, Mads Thomassen, Nicholas A. Sinnott-Armstrong, 2016 .

PALB2: research reaching to clinical outcomes for women with breast cancer

Melissa C. Southey, Ingrid Winship, Tú Nguyen-Dumont, 2016, Hereditary Cancer in Clinical Practice.

Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

Patrick Neven, Hui Zhao, Nazneen Rahman, 2012, PloS one.

Explaining Variance in the Cumulus Mammographic Measures That Predict Breast Cancer Risk: A Twins and Sisters Study

Graham G. Giles, Enes Makalic, Carmel Apicella, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

Joshua M. Korn, Christiana Kartsonaki, Amanda B. Spurdle, 2010, PLoS Genetics.

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

Brooke L. Fridley, Matthias W. Beckmann, Peter A. Fasching, 2013, Nature Genetics.

Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies

Päivi Heikkilä, Carlos Caldas, Simon S. Cross, 2010, PLoS medicine.

Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees

Simon Easteal, Gavin A. Huttley, Graham G. Giles, 2000, Nature Genetics.

Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

Dong Liang, Brooke L. Fridley, Jennifer A. Doherty, 2015, Cancer Epidemiology, Biomarkers & Prevention.

The Role of New Sequencing Technology in Identifying Rare Mutations in New Susceptibility Genes for Cancer

Melissa C. Southey, M. Southey, 2013, Current Genetic Medicine Reports.

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Päivi Heikkilä, Mads Thomassen, Stephen Fox, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer

Andrew Lonie, Graham G. Giles, Laura Baglietto, 2014, Breast Cancer Research and Treatment.

Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors

Patrick Neven, Daniel F. Schmidt, Julian Peto, 2013, PLoS genetics.

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

Alison P. Klein, William Wheeler, Li Jin, 2015 .

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

Matthias W. Beckmann, Peter A. Fasching, Nur Aishah Mohd Taib, 2014, Nature Communications.

Genome-wide association study identiﬁes multiple loci associated with both mammographic density and breast cancer risk

Heang-Ping Chan, Mark A. Helvie, Andrew H. Beck, 2022 .